From: The economic burden of systemic sclerosis related pulmonary arterial hypertension in Australia
Per annum cost from PAH diagnosis | Hospitalization mean±SD median (IQR) | ED Presentation mean±SD median (IQR) | Ambulatory care mean±SD median (IQR) | Total healthcare cost mean±SD median (IQR) |
---|---|---|---|---|
1st year of diagnosis | ||||
mean cost | 11,016 ± 22,971 | 283 ± 626 | 3,019 ± 4,626 | 14,319 ± 27,040 |
median cost | 1,008 (0-11,133) | 0 (0-374) | 2,458 (0-3,979) | 4,125 (0-15,666) |
2nd year of diagnosis | ||||
mean cost | 7,240 ± 18,511 | 222 ± 453 | 2,190 ± 2,337 | 9,653 ± 19,833 |
median cost | 0 (0 – 4,766) | 0 (0-360) | 1,740 (416-3,168) | 2,737 (668 – 8,924) |
3rd year of diagnosis | ||||
mean cost | 6,002 ± 12,527 | 291 ± 640 | 2,029 ± 2,068 | 8,324 ± 13,748 |
median cost | 0 (0-6,204) | 0 (0-384) | 1,554 (210 – 3,144) | 3,579 (429-9,486) |
4th year of diagnosis | ||||
mean cost | 6,233 ± 13,729 | 199 ± 379 | 1,904 ± 2,156 | 8,336 ± 14,871 |
median cost | 0 (0-6,962) | 0 (0-384) | 1,373 (0-2,988) | 2,446 (0-10,980) |
5th year of diagnosis | ||||
mean cost | 5,080 ± 11,575 | 178 ± 433 | 1,890 ± 2,402 | 7,149 ± 12,903 |
median cost | 0 (0-1,681) | 0 (0-0) | 1,178 (0-2,908) | 1,755 (0-6,602) |